Literature DB >> 35907156

PET/contrast-enhanced CT in oncology: "to do, or not to do, that is the question".

Michele Scialpi1, Tullo Ostilio Moschini2, Giuseppe De Filippis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35907156     DOI： 10.1007/s11547-022-01496-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN： 0033-8362            Impact factor:   6.313


× No keyword cloud information.
  3 in total

1.  Single-phase Whole-body 64-MDCT Split-bolus Protocol for Pediatric Oncology: Diagnostic Efficacy and Dose Radiation.

Authors:  Michele Scialpi; Raffaele Schiavone; Alfredo D'Andrea; Isabella Palumbo; Michelle Magli; Sabrina Gravante; Giuseppe Falcone; Claudio De Filippi; Lucia Manganaro; Barbara Palumbo
Journal:  Anticancer Res       Date:  2015-05       Impact factor: 2.480

Review 2.  To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.

Authors:  Gerald Antoch; Lutz S Freudenberg; Thomas Beyer; Andreas Bockisch; Jörg F Debatin
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

3.  Detection and characterization of focal liver lesions by split-bolus multidetector-row CT: diagnostic accuracy and radiation dose in oncologic patients.

Authors:  Michele Scialpi; Barbara Palumbo; Luisa Pierotti; Sabrina Gravante; Alessio Piunno; Alberto Rebonato; Alfredo D'Andrea; Alfonso Reginelli; Irene Piscioli; Luca Brunese; Antonio Rotondo
Journal:  Anticancer Res       Date:  2014-08       Impact factor: 2.480
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.